IVAX Names Marcus Senior Vice President For IVAX Research

     
BW20030327002127  20030328T070143Z UTC


( BW)(IVAX-CORPORATION)(IVX) IVAX Names Marcus Senior Vice President
For IVAX Research

    Business Editors
    UK REGULATORY NEWS

    MIAMI--(BUSINESS WIRE)--March 28, 2003--

IVAX Corporation (AMEX:IVX) (LSE:IVX.L) announced today that Stephen
Marcus, M.D. has been appointed senior vice president, proprietary
pharmaceutical business development - IVAX Research, Inc. Dr. Marcus
will report to Dr. Phillip Frost, chairman and CEO of IVAX.

Dr. Marcus has extensive drug development experience, including the
development of new drugs to treat multiple sclerosis, various forms of
cancer and other diseases. He has played a major role in IVAX'
collaborations with the National Cancer Institute regarding a number
of immunotoxins for cancer and HIV, as well as with IVAX'
collaboration with Serono regarding cladribine for multiple sclerosis.
Dr. Marcus' entrepreneurial spirit and medical and scientific
expertise will be invaluable as IVAX enters into further proprietary
product collaborations around the world with other pharmaceutical
companies.

Dr. Marcus joined IVAX Research as vice president, oncology and
biotechnology in October 1999. Prior to joining IVAX Research, he held
senior clinical research positions with Neurocrine Biosciences,
Novartis Pharmaceuticals, Schering-Plough Corporation and Triton
Biosciences, the biotechnology subsidiary of Shell Oil Company.

IVAX Corporation, headquartered in Miami, Florida, discovers,
develops, manufactures, and markets branded and brand equivalent
(generic) pharmaceuticals and veterinary products in the U.S. and
internationally.

Copies of this and other news releases may be obtained free of charge
from IVAX' website at http://www.ivax.com.

   Short Name: IVAX Corporation
   Category Code: MSC
   Sequence Number: 00003403
   Time of Receipt (offset from UTC): 20030327T171544+0000

    --30--JD/mi* mh/uk

    CONTACT: IVAX Corporation, Miami
             Jim Whitlow, 305/575-6043

    KEYWORD: FLORIDA UNITED KINGDOM INTERNATIONAL EUROPE
    INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL MANAGEMENT CHANGES
    SOURCE: IVAX Corporation

Today's News On The Net - Business Wire's full file on the Internet
                          with Hyperlinks to your home page.
                          URL: http://www.businesswire.com